Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ)

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Laboratory Safety of Dupilumab in Moderate‐to‐severe Atopic Dermatitis: Results From Three Phase III Trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )

British Journal of Dermatology
DermatologyMedicine
2019English

Pss43 - Dupilumab Improves Absenteeism in Moderate-To-Severe Atopic Dermatitis Patients Compared With Placebo in Phase 3 Liberty Ad Solo Studies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Dupilumab in Moderate-To-Severe Atopic Dermatitis With or Without Comorbid Food Allergy: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD

Journal of Allergy and Clinical Immunology: In Practice
AllergyImmunology
2019English

673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Dupilumab Consistently Improves Rhinoconjunctivitis-Specific Health-Related Quality of Life in Patients With Uncontrolled, Moderate-To-Severe Asthma and Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-To-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy